Clinical Trials
29 trialsHYDRA
Leiden University Medical Center
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
EPLLMMRDC
North Sichuan Medical College
On Dose Efficiency of Modern CT-scanners in Chest Scans
University Hospital Augsburg
CANVAS
Alliance Foundation Trials, LLC.
VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program
Nordsjaellands Hospital
ACTIV4
Eurasian Association of Therapists
The Incidence of Pulmonary Embolism During Nephrectomy
Mahidol University
Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
M.D. Anderson Cancer Center
PAP-UP
Thomas Jefferson University
LISSE1
Centre Hospitalier Régional d'Orléans
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
McMaster University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
G. d'Annunzio University
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
REMARK
Ottawa Hospital Research Institute
Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease
Delos Clinical
MICA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
UPP
University of Milan
SOME
Ottawa Hospital Research Institute
Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection
McMaster University
PERI-OP
Ottawa Hospital Research Institute
GIVTE
University of Aarhus
3 Screen Electronic Alert
Brigham and Women's Hospital
Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population
Memorial Sloan Kettering Cancer Center
Epidemiology of Venous Thromboembolism
Brigham and Women's Hospital
Multi-Center Human Alert Trial to Prevent DVT and PE
Brigham and Women's Hospital
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Ontario Clinical Oncology Group (OCOG)